Davis Polk has advised Interra Acquisition Corporation, while Freshfields Bruckhaus Deringer has advised ABCI Capital and J.P. Morgan. ABCI Capital and J.P. Morgan, the joint sponsors...
Interra Acquisition Corporation’s SPAC Listing
InSilico Medicine’s $35 Million Series D2 Financing
Davis Polk advised InSilico Medicine in the transaction. InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million....
InSilico Medicine’s $60 Million Series D Financing
Davis Polk advised InSilico Medicine in the transaction. InSilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, closed its $60 million Series D financing...